APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liquid Embolic System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Liquid Embolic System Market Outlook and Growth Opportunities 2026

4 July 2026198 pages

Choose your research edition.

Industry ResearchLiquid Embolic System Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Liquid Embolic System Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Liquid Embolic System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liquid Embolic System Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Liquid Embolic System Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Liquid Embolic System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Liquid Embolic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Liquid Embolic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liquid Embolic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Liquid Embolic System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Liquid Embolic System market include Medtronic, Terumo, Saikesaisi Holding, MicroVention, Meril Life, CERENOVUS and Balt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Liquid Embolic System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Liquid Embolic System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Liquid Embolic System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Liquid Embolic System market size, projected growth trends, production technologies, key applications, and end-use industries.

Liquid Embolic System Segment by Company

Medtronic

Terumo

Saikesaisi Holding

MicroVention

Meril Life

CERENOVUS

Balt

Liquid Embolic System Segment by Type

6% EVOH

8% EVOH

Liquid Embolic System Segment by Application

Arteriovenous Malformations

Hypervascular Tumors

Other

Liquid Embolic System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Liquid Embolic System status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Liquid Embolic System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Liquid Embolic System significant trends, drivers, influence factors in global and regions.

6. To analyze Liquid Embolic System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liquid Embolic System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liquid Embolic System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liquid Embolic System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Liquid Embolic System market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Liquid Embolic System industry.

Chapter 3: Detailed analysis of Liquid Embolic System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Liquid Embolic System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Liquid Embolic System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Liquid Embolic System Industry Trends Table 2. Liquid Embolic System Industry Drivers Table 3. Liquid Embolic System Industry Opportunities and Challenges Table 4. Liquid Embolic System Industry Restraints Table 5. Global Liquid Embolic System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Liquid Embolic System Revenue Share by Company (2021-2026) Table 7. Global Liquid Embolic System Sales Volume by Company (k units) & (2021-2026) Table 8. Global Liquid Embolic System Sales Volume Share by Company (2021-2026) Table 9. Global Liquid Embolic System Average Price (USD/unit) of Company (2021-2026) Table 10. Global Liquid Embolic System Company Ranking, (2024-2026) & (USD Million) Table 11. Global Liquid Embolic System Key Company Manufacturing Base & Headquarters Table 12. Global Liquid Embolic System Company, Product Type & Application Table 13. Global Liquid Embolic System Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Liquid Embolic System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 6% EVOH Table 18. Significant Companies of 8% EVOH Table 19. Global Liquid Embolic System Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Liquid Embolic System Sales Volume by Type (2021-2026) & (k units) Table 21. Global Liquid Embolic System Sales Volume by Type (2027-2032) & (k units) Table 22. Global Liquid Embolic System Sales Volume Share by Type (2021-2026) Table 23. Global Liquid Embolic System Sales Volume Share by Type (2027-2032) Table 24. Global Liquid Embolic System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Liquid Embolic System Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Liquid Embolic System Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Liquid Embolic System Sales Value Share by Type (2021-2026) Table 28. Global Liquid Embolic System Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Arteriovenous Malformations Table 30. Significant Companies of Hypervascular Tumors Table 31. Significant Companies of Other Table 32. Global Liquid Embolic System Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Liquid Embolic System Sales Volume by Application (2021-2026) & (k units) Table 34. Global Liquid Embolic System Sales Volume by Application (2027-2032) & (k units) Table 35. Global Liquid Embolic System Sales Volume Share by Application (2021-2026) Table 36. Global Liquid Embolic System Sales Volume Share by Application (2027-2032) Table 37. Global Liquid Embolic System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Liquid Embolic System Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Liquid Embolic System Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Liquid Embolic System Sales Value Share by Application (2021-2026) Table 41. Global Liquid Embolic System Sales Value Share by Application (2027-2032) Table 42. Global Liquid Embolic System Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Liquid Embolic System Sales by Region (2021-2026) & (k units) Table 44. Global Liquid Embolic System Sales Market Share by Region (2021-2026) Table 45. Global Liquid Embolic System Sales by Region (2027-2032) & (k units) Table 46. Global Liquid Embolic System Sales Market Share by Region (2027-2032) Table 47. Global Liquid Embolic System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Liquid Embolic System Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Liquid Embolic System Sales Value Share by Region (2021-2026) Table 50. Global Liquid Embolic System Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Liquid Embolic System Sales Value Share by Region (2027-2032) Table 52. Global Liquid Embolic System Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Liquid Embolic System Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Liquid Embolic System Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Liquid Embolic System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Liquid Embolic System Sales by Country (2021-2026) & (k units) Table 57. Global Liquid Embolic System Sales Market Share by Country (2021-2026) Table 58. Global Liquid Embolic System Sales by Country (2027-2032) & (k units) Table 59. Global Liquid Embolic System Sales Market Share by Country (2027-2032) Table 60. Global Liquid Embolic System Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Liquid Embolic System Sales Value Market Share by Country (2021-2026) Table 62. Global Liquid Embolic System Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Liquid Embolic System Sales Value Market Share by Country (2027-2032) Table 64. Medtronic Company Information Table 65. Medtronic Business Overview Table 66. Medtronic Liquid Embolic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Medtronic Liquid Embolic System Product Portfolio Table 68. Medtronic Recent Development Table 69. Terumo Company Information Table 70. Terumo Business Overview Table 71. Terumo Liquid Embolic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Terumo Liquid Embolic System Product Portfolio Table 73. Terumo Recent Development Table 74. Saikesaisi Holding Company Information Table 75. Saikesaisi Holding Business Overview Table 76. Saikesaisi Holding Liquid Embolic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Saikesaisi Holding Liquid Embolic System Product Portfolio Table 78. Saikesaisi Holding Recent Development Table 79. MicroVention Company Information Table 80. MicroVention Business Overview Table 81. MicroVention Liquid Embolic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. MicroVention Liquid Embolic System Product Portfolio Table 83. MicroVention Recent Development Table 84. Meril Life Company Information Table 85. Meril Life Business Overview Table 86. Meril Life Liquid Embolic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Meril Life Liquid Embolic System Product Portfolio Table 88. Meril Life Recent Development Table 89. CERENOVUS Company Information Table 90. CERENOVUS Business Overview Table 91. CERENOVUS Liquid Embolic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. CERENOVUS Liquid Embolic System Product Portfolio Table 93. CERENOVUS Recent Development Table 94. Balt Company Information Table 95. Balt Business Overview Table 96. Balt Liquid Embolic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Balt Liquid Embolic System Product Portfolio Table 98. Balt Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Liquid Embolic System Distributors List Table 102. Liquid Embolic System Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Liquid Embolic System Product Image Figure 2. Global Liquid Embolic System Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liquid Embolic System Sales Value (2021-2032) & (US$ Million) Figure 4. Global Liquid Embolic System Sales (2021-2032) & (k units) Figure 5. Global Liquid Embolic System Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Liquid Embolic System Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 6% EVOH Image Figure 10. 8% EVOH Image Figure 11. Global Liquid Embolic System Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Liquid Embolic System Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Liquid Embolic System Sales Volume Share by Type (2021-2032) Figure 14. Global Liquid Embolic System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Liquid Embolic System Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Liquid Embolic System Sales Value Share by Type (2021-2032) Figure 17. Arteriovenous Malformations Image Figure 18. Hypervascular Tumors Image Figure 19. Other Image Figure 20. Global Liquid Embolic System Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Liquid Embolic System Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Liquid Embolic System Sales Volume Share by Application (2021-2032) Figure 23. Global Liquid Embolic System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Liquid Embolic System Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Liquid Embolic System Sales Value Share by Application (2021-2032) Figure 26. Global Liquid Embolic System Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Liquid Embolic System Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Liquid Embolic System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Liquid Embolic System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Liquid Embolic System Sales Value (2021-2032) & (US$ Million) Figure 31. North America Liquid Embolic System Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Liquid Embolic System Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Liquid Embolic System Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Liquid Embolic System Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Liquid Embolic System Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Liquid Embolic System Sales Value (2021-2032) & (US$ Million) Figure 37. South America Liquid Embolic System Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Liquid Embolic System Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Liquid Embolic System Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Liquid Embolic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Liquid Embolic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Liquid Embolic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Liquid Embolic System Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Liquid Embolic System Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 6% EVOH
  • 8% EVOH
Applications
  • Arteriovenous Malformations
  • Hypervascular Tumors
  • Other
Companies covered
  • Medtronic
  • Terumo
  • Saikesaisi Holding
  • MicroVention
  • Meril Life
  • CERENOVUS
  • Balt

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Liquid Embolic System Sales Value (2021-2032)
  4. 1.2.2 Global Liquid Embolic System Sales Volume (2021-2032)
  5. 1.2.3 Global Liquid Embolic System Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Liquid Embolic System Market Dynamics
  1. 2.1 Liquid Embolic System Industry Trends
  2. 2.2 Liquid Embolic System Industry Drivers
  3. 2.3 Liquid Embolic System Industry Opportunities and Challenges
  4. 2.4 Liquid Embolic System Industry Restraints
3 Liquid Embolic System Market by Company
  1. 3.1 Global Liquid Embolic System Company Revenue Ranking in 2025
  2. 3.2 Global Liquid Embolic System Revenue by Company (2021-2026)
  3. 3.3 Global Liquid Embolic System Sales Volume by Company (2021-2026)
  4. 3.4 Global Liquid Embolic System Average Price by Company (2021-2026)
  5. 3.5 Global Liquid Embolic System Company Ranking (2024-2026)
  6. 3.6 Global Liquid Embolic System Company Manufacturing Base and Headquarters
  7. 3.7 Global Liquid Embolic System Company Product Type and Application
  8. 3.8 Global Liquid Embolic System Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Liquid Embolic System Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Liquid Embolic System Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Liquid Embolic System Market by Type
  1. 4.1 Liquid Embolic System Type Introduction
  2. 4.1.1 6% EVOH
  3. 4.1.2 8% EVOH
  4. 4.2 Global Liquid Embolic System Sales Volume by Type
  5. 4.2.1 Global Liquid Embolic System Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Liquid Embolic System Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Liquid Embolic System Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Liquid Embolic System Sales Value by Type
  9. 4.3.1 Global Liquid Embolic System Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Liquid Embolic System Sales Value by Type (2021-2032)
  11. 4.3.3 Global Liquid Embolic System Sales Value Share by Type (2021-2032)
5 Liquid Embolic System Market by Application
  1. 5.1 Liquid Embolic System Application Introduction
  2. 5.1.1 Arteriovenous Malformations
  3. 5.1.2 Hypervascular Tumors
  4. 5.1.3 Other
  5. 5.2 Global Liquid Embolic System Sales Volume by Application
  6. 5.2.1 Global Liquid Embolic System Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liquid Embolic System Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Liquid Embolic System Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Liquid Embolic System Sales Value by Application
  10. 5.3.1 Global Liquid Embolic System Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Liquid Embolic System Sales Value by Application (2021-2032)
  12. 5.3.3 Global Liquid Embolic System Sales Value Share by Application (2021-2032)
6 Liquid Embolic System Regional Sales and Value Analysis
  1. 6.1 Global Liquid Embolic System Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Liquid Embolic System Sales by Region (2021-2032)
  3. 6.2.1 Global Liquid Embolic System Sales by Region: 2021-2026
  4. 6.2.2 Global Liquid Embolic System Sales by Region (2027-2032)
  5. 6.3 Global Liquid Embolic System Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Liquid Embolic System Sales Value by Region (2021-2032)
  7. 6.4.1 Global Liquid Embolic System Sales Value by Region: 2021-2026
  8. 6.4.2 Global Liquid Embolic System Sales Value by Region (2027-2032)
  9. 6.5 Global Liquid Embolic System Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Liquid Embolic System Sales Value (2021-2032)
  12. 6.6.2 North America Liquid Embolic System Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Liquid Embolic System Sales Value (2021-2032)
  15. 6.7.2 Europe Liquid Embolic System Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Liquid Embolic System Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Liquid Embolic System Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Liquid Embolic System Sales Value (2021-2032)
  21. 6.9.2 South America Liquid Embolic System Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Liquid Embolic System Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Liquid Embolic System Sales Value Share by Country, 2025 VS 2032
7 Liquid Embolic System Country-level Sales and Value Analysis
  1. 7.1 Global Liquid Embolic System Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Liquid Embolic System Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Liquid Embolic System Sales by Country (2021-2032)
  4. 7.3.1 Global Liquid Embolic System Sales by Country (2021-2026)
  5. 7.3.2 Global Liquid Embolic System Sales by Country (2027-2032)
  6. 7.4 Global Liquid Embolic System Sales Value by Country (2021-2032)
  7. 7.4.1 Global Liquid Embolic System Sales Value by Country (2021-2026)
  8. 7.4.2 Global Liquid Embolic System Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Liquid Embolic System Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Liquid Embolic System Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Liquid Embolic System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Liquid Embolic System Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Liquid Embolic System Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Liquid Embolic System Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Liquid Embolic System Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Liquid Embolic System Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Liquid Embolic System Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Liquid Embolic System Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Liquid Embolic System Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Liquid Embolic System Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Liquid Embolic System Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Liquid Embolic System Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Liquid Embolic System Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Liquid Embolic System Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Liquid Embolic System Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Liquid Embolic System Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Liquid Embolic System Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Liquid Embolic System Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Liquid Embolic System Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Liquid Embolic System Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Liquid Embolic System Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Liquid Embolic System Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Liquid Embolic System Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Liquid Embolic System Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Liquid Embolic System Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Liquid Embolic System Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Liquid Embolic System Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Liquid Embolic System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Liquid Embolic System Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Liquid Embolic System Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Terumo
  8. 8.2.1 Terumo Company Information
  9. 8.2.2 Terumo Business Overview
  10. 8.2.3 Terumo Liquid Embolic System Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Terumo Liquid Embolic System Product Portfolio
  12. 8.2.5 Terumo Recent Developments
  13. 8.3 Saikesaisi Holding
  14. 8.3.1 Saikesaisi Holding Company Information
  15. 8.3.2 Saikesaisi Holding Business Overview
  16. 8.3.3 Saikesaisi Holding Liquid Embolic System Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Saikesaisi Holding Liquid Embolic System Product Portfolio
  18. 8.3.5 Saikesaisi Holding Recent Developments
  19. 8.4 MicroVention
  20. 8.4.1 MicroVention Company Information
  21. 8.4.2 MicroVention Business Overview
  22. 8.4.3 MicroVention Liquid Embolic System Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 MicroVention Liquid Embolic System Product Portfolio
  24. 8.4.5 MicroVention Recent Developments
  25. 8.5 Meril Life
  26. 8.5.1 Meril Life Company Information
  27. 8.5.2 Meril Life Business Overview
  28. 8.5.3 Meril Life Liquid Embolic System Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Meril Life Liquid Embolic System Product Portfolio
  30. 8.5.5 Meril Life Recent Developments
  31. 8.6 CERENOVUS
  32. 8.6.1 CERENOVUS Company Information
  33. 8.6.2 CERENOVUS Business Overview
  34. 8.6.3 CERENOVUS Liquid Embolic System Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CERENOVUS Liquid Embolic System Product Portfolio
  36. 8.6.5 CERENOVUS Recent Developments
  37. 8.7 Balt
  38. 8.7.1 Balt Company Information
  39. 8.7.2 Balt Business Overview
  40. 8.7.3 Balt Liquid Embolic System Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Balt Liquid Embolic System Product Portfolio
  42. 8.7.5 Balt Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Liquid Embolic System Value Chain Analysis
  2. 9.1.1 Liquid Embolic System Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Liquid Embolic System Sales Mode & Process
  6. 9.2 Liquid Embolic System Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Liquid Embolic System Distributors
  9. 9.2.3 Liquid Embolic System Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst